Adverse effects of voriconazoleLOHR, Lisa.Orthopedics (Thorofare). 2004, Vol 27, Num 5, pp 472-473, issn 0147-7447, 2 p.Article

Voriconazole for serious fungal infectionsGOTHARD, P; ROGERS, T. R.International journal of clinical practice (Esher). 2004, Vol 58, Num 1, pp 74-80, issn 1368-5031, 7 p.Article

Clinical pharmacokinetics of voriconazoleLEVEQUE, Dominique; NIVOIX, Yasmine; JEHL, Francois et al.International journal of antimicrobial agents. 2006, Vol 27, Num 4, pp 274-284, issn 0924-8579, 11 p.Article

Treatment of Scedosporiosis with Voriconazole : Clinical Experience with 107 PatientsTROKE, Peter; AGUIRREBENGOA, Koldo; ARTEAGA, Carmen et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 5, pp 1743-1750, issn 0066-4804, 8 p.Article

Successful topical therapy with voriconazole : Pseudallescheriasis after injuryTAMMER, Ina; SEIBOLD, Michael; KRAUSE, Hardy et al.The Journal of trauma, injury, infection, and critical care. 2007, Vol 62, Num 5, pp 1295-1297, issn 1079-6061, 3 p.Conference Paper

Successful treatment of brain aspergillosis with voriconazoleTATTEVIN, P; BRUNEEL, F; LELLOUCHE, F et al.Clinical microbiology and infection. 2004, Vol 10, Num 10, pp 928-931, issn 1198-743X, 4 p.Article

Nouveaux antifongiques systémiques = New antifungalsCAZENAVE, B; LANTERNIER, F; LORTHOLARY, O et al.La Lettre de l'infectiologue. 2010, Vol 25, Num 5, pp 178-184, issn 0296-9009, 7 p.Article

Voriconazole Use for Endemic Fungal Infections 7FREIFELD, Alison; PROIA, Laurie; ANDES, David et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 4, pp 1648-1651, issn 0066-4804, 4 p.Article

Disposition of voriconazole during continuous veno-venous haemodiafiltration (CVVHDF) in a single patientROBATEL, C; RUSCA, M; PADOIN, C et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 54, Num 1, pp 269-270, issn 0305-7453, 2 p.Article

Effet rebond après utilisation du voriconazole dans le traitement de l'ABPA = Rebound after ABPA treatment with voriconazoleMULLIEZ, P; CROXO, C; SAINT-GEORGES, F.-R et al.Revue des maladies respiratoires. 2010, Vol 27, Num 7, pp 786-787, issn 0761-8425, 2 p.Article

Voriconazole Pharmacokinetics in Liver Transplant RecipientsJOHNSON, H. J; HAN, K; ROMKES, M et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 2, pp 852-859, issn 0066-4804, 8 p.Article

Pharmacokinetics of Intracameral Voriconazole InjectionSHEN, Ying-Cheng; WANG, Mei-Yen; WANG, Chun-Yuan et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 5, pp 2156-2157, issn 0066-4804, 2 p.Article

Clearance of intravitreal voriconazoleSBEN, Ying-Cheng; WANG, Mei-Yen; WANG, Chun-Yuan et al.Investigative ophthalmology & visual science. 2007, Vol 48, Num 5, pp 2238-2241, issn 0146-0404, 4 p.Article

Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazolePFALLER, M. A; ESPINEL-INGROFF, A; JONES, R. N et al.Journal of clinical microbiology (Print). 2004, Vol 42, Num 10, pp 4577-4580, issn 0095-1137, 4 p.Article

Quality control limits for voriconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene bluePFALLER, M. A; BARRY, A; BILLE, J et al.Journal of clinical microbiology (Print). 2004, Vol 42, Num 4, pp 1716-1718, issn 0095-1137, 3 p.Article

Visual disturbance comorbid with hallucination caused by voriconazole in the Japanese populationIMATAKI, Osamu; OHNISHI, Hiroaki; KITANAKA, Akira et al.International journal of hematology. 2008, Vol 88, Num 1, pp 3-6, issn 0925-5710, 4 p.Article

The effects of caspofungin and voriconazole in an experimental fungal infection of the ear due to AspergillusAYCICEK, Abdullah; CETINKAYA, Zafer; KIYICI, Halil et al.European archives of oto-rhino-laryngology. 2009, Vol 266, Num 11, pp 1703-1709, issn 0937-4477, 7 p.Article

Two cases of subcutaneous Scedosporium apiospermum infection treated with voriconazoleBOSMA, F; VOSS, A; VAN HAMERSVELT, H. W et al.Clinical microbiology and infection. 2003, Vol 9, Num 7, pp 750-753, issn 1198-743X, 4 p.Article

Clinical Images: Voriconazole-induced periostitis deformansBECCE, Fabio; MALGHEM, Jacques; LECOUVET, Frederic E et al.Arthritis and rheumatism. 2012, Vol 64, Num 10, issn 0004-3591, p. 3490Article

Voriconazole susceptibility of yeasts isolated from the mouths of patients with advanced cancerBAGG, Jeremy; SWEENEY, M. Petrina; DAVIES, Andrew N et al.Journal of medical microbiology. 2005, Vol 54, Num 10, pp 959-964, issn 0022-2615, 6 p.Article

Penetration of Voriconazole, 1%, Eyedrops Into Human Aqueous Humor : A Prospective Open-Label StudyLAU, David; FEDINANDS, Mervyn; LEUNG, Lok et al.Archives of ophthalmology (1960). 2008, Vol 126, Num 3, pp 343-346, issn 0003-9950, 4 p.Article

Treatment of protothecosis with voriconazoleDALMAU, Joan; PIMENTEL, Carmen L; ALEGRE, Marta et al.Journal of the American Academy of Dermatology. 2006, Vol 55, Num 5, issn 0190-9622, S122-S123, SUPArticle

Administration of Voriconazole in Patients With Renal DysfunctionNEOFYTOS, Dionissios; LOMBARDI, Lindsey R; SHIELDS, Ryan K et al.Clinical infectious diseases. 2012, Vol 54, Num 7, pp 913-921, issn 1058-4838, 9 p.Article

Integrated Population Pharmacokinetic Analysis of Voriconazole in Children, Adolescents, and AdultsFRIBERG, Lena E; RAVVA, Patanjali; KARLSSON, Mats O et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 6, pp 3032-3042, issn 0066-4804, 11 p.Article

DISSEMINATED CUTANEOUS HISTOPLASMOSIS IN AN IMMUNOCOMPETENT CHILD, RELAPSED WITH ITRACONAZOLE, SUCCESSFULLY TREATED WITH VORICONAZOLEDHAWAN, Jyoti; VERMA, Parul; SHARMA, Alok et al.Pediatric dermatology. 2010, Vol 27, Num 5, pp 549-551, issn 0736-8046, 3 p.Article